DGAP-News: MediClin AG / Key word(s): Quarterly / Interim Statement
MEDICLIN startet well into the FY 2019

06.05.2019 / 13:30
The issuer is solely responsible for the content of this announcement.


Offenburg, 6 May 2019

MEDICLIN startet well into the FY 2019

In the first quarter of 2019, Group sales of MEDICLIN Aktiengesellschaft (MEDICLIN) of EUR 167.6 mill. were 6.1 % or EUR 9.7 mill. higher than in the comparable prior-year quarter. Sales in the post-acute segment rose by EUR 7.0 mill., while sales in the acute segment climbed by EUR 2.5 mill. Sales in the nursing care business area were slightly higher than the prior-year level.

The reported Group operating result for the first quarter amounts to EUR 1.6 mill. (Q1 2018: EUR 0.7 mill.). The segment result of the post-acute segment came out to EUR 2.9 mill., whereas the segment result of the acute segment was EUR -0.5 mill.

Gross investments amounted to EUR 11.2 mill. in the first three months of the 2019 financial year (Q1 2018: EUR 9.5 mill.), pertaining mainly to the reconstruction and expansion of clinics and the acquisition of medical equipment. Capital expenditure is thus in line with the annual budget. Cash and cash equivalents as of 31 March 2019 amounted to EUR 21.7 mill. (31.12.2018: EUR 33.8 mill.).

Outlook

The sales increase in the first quarter of 2019 implies a good start into the new financial year and the earnings performance is in line with the usual performance in the first three months of a year. Therefore the Management Board assumes that the forecast for the 2019 financial year can be met.

The corporate strategy of MEDICLIN provides a sales growth strategy. Only then the legislator's regulatory requirements can be fulfilled and cost increases at least partially compensated. The expenses for skilled staff, in particular, will continue to increase significantly in the health sector in 2019.

The interim report as of 31 March 2019 is available on the homepage of MEDICLIN in German and English from today on. www.mediclin.de

/

About MEDICLIN AG (Ticker: MED; WKN: 659 510)

MEDICLIN owns 36 clinics, seven nursing care facilities, two home nursing care services and ten medical care centres. The Group has about 8,350 beds and a headcount of more than 10,000. With its strong network, MEDICLIN can offer its patients integrated care from the first visit to the doctor to surgery, post-operative rehabilitation and follow-up care at home. Doctors, therapists and nurses work together closely to achieve the best results. MEDICLIN plans the care of persons in need in accordance with their individual requirements and personal needs, either at home or in a nursing care facility.

MEDICLIN - A company of the Asklepios Group.



06.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MediClin AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: alexandra.muehr@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 807447

 
End of News DGAP News Service

807447  06.05.2019 

fncls.ssp?fn=show_t_gif&application_id=807447&application_name=news&site_id=zonebourse